Where does Seven Bridges Genomics Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Seven Bridges Genomics Inc. ranks #5,320 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Seven Bridges Genomics Inc. hold?

Seven Bridges Genomics Inc. holds 65 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Seven Bridges Genomics Inc.'s Innovation Score?

Seven Bridges Genomics Inc. has an Innovation Score of 42.2 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Seven Bridges Genomics Inc.'s patent grant rate increasing or decreasing?

Seven Bridges Genomics Inc.'s recent grant velocity is +95% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Seven Bridges Genomics Inc.'s patents?

Seven Bridges Genomics Inc.'s patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Seven Bridges Genomics Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Seven Bridges Genomics Inc.

Q: What technology areas does Seven Bridges Genomics Inc. focus on?

Seven Bridges Genomics Inc.'s top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 60 patents, ranking #9 of 676 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 65 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Seven ranks #5,320 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 11 technology areas.

#5,320
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.2/100): 18.6
avg claims per patent: +95%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5320 · US Corporation #5,320 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 65 grants
UPPER-Q #5,320/49,997
PHOTO-FINISH Schneider Toshiba…
CPC-FOCUS G16B · 11 areas
INNOV-PAR 42.2/100
CLAIMS-RICH 18.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +95% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Schneider Toshiba Inverter Europe SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Seven’s 42.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.5 pts (34%) Velocity 4.8 pts (11%) Breadth 11.7 pts (28%) Claim depth 11.2 pts (27%)

Qualcomm Incorporated · highest

85
ConnectWise · near

42
Iseki & · near

42
Medtronic PS Medical · near

42
Seven Bridges Genomics · this assignee

42
Sybase · near

42
3D Lighting… · lowest

7

What this shows Seven's Innovation Score is 42.2/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Seven?

Each dot is one of Seven’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Seven’s own 18.6 claims/patent is ABOVE the 8.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Seven vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Seven's grants concentrate

Seven Bridges Genomics Inc. is a focused PatentsView assignee: 11 CPC subclasses with 92.3% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2020 (13 grants) versus a trough of 1 in 2016. By volume, Seven sits between SDS Asia Limited, BVI #1748971 and Subsea 7 Limited.

Seven's three-year grant acceleration

From 2019–2021 to 2022–2024, Seven Bridges Genomics Inc. moved from 29 to 21 grants (0.72x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

SDS Asia BVI #174…

65
Seikagaku

65
SPR Therapeutics

65
Schneider Toshiba…

65
Shenzhen Grandsun

65
Shock Doctor

65
Sonic IP

65
Subsea 7

65
Seven Bridges Gen… ◀

65

What this shows Seven holds 65 patents at rank #5,320, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Seven

By rank, the assignees closest to #5,320 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Seven's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Seven, neither rank-band nor same-CPC leaders (those blocks stay above). In G16B (Bioinformatics), Seven ranks #9 of 676 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Iseki & Co., Ltd. 42 Medtronic PS Medical, Inc. 42 Sybase, Inc. 42 ConnectWise, LLC 42

Similar claim depth

Nearest assignees by average claims per patent (18.6 here).

Liebherr-werk Biberach GMBH 18.6 avg Caavo Inc 18.6 avg Bettcher Industries, Inc. 18.6 avg Amphenol Corporation 18.6 avg

Seven's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Seven Bridges Genomics Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	4.6%
2016	1	1.5%
2017	2	3.1%
2018	6	9.2%
2019	9	13.8%
2020	13	20.0%
2021	7	10.8%
2022	8	12.3%
2023	8	12.3%
2024	5	7.7%
2025partial year	3	4.6%

Which technologies does Seven Bridges Genomics Inc. patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 60

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 21

G06F - Electric Digital Data Processing 17

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 5

H03M - CODING; DECODING; Code Conversion IN General 3

G06T - Image Data Processing OR Generation, IN General 2

G06V - Image OR Video Recognition OR Understanding 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Seven Bridges Genomics Inc.'s patent record in context - here's where to go next.

Seven Bridges Genomics Inc.'s lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 92.3% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #5,320 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Seven Bridges Genomics Inc. against SDS Asia Limited, BVI #1748971, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.